+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 46207

Chapter 46207 provides scholary research titles of which PDF Full Texts are available through EurekaMag.

Farahat, M.N., 1997:
HLA-DR expression in synovial membrane of juvenile rheumatoid arthritis (JRA) versus osteoarthritis (OA)

Roudier, J., 1995:
HLA-DR genotyping, diagnosis and prognosis of inflammatory arthritis

Arellanes-García, L.; Bautista, N.; Mora, P.; Ortega-Larrocea, G.; Burguet, A.; Gorodezky, C., 1998:
HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients

Bignon, J.D.; Nataf, S.; Hourmant, M.; Cesbron, A.; Soulillou, J.P.; Muller, J.Y., 1993:
HLA-DR matching assessed by DNA analysis in kidney transplantation--a one-center study

Leivestad, T.; Foerster, A.; Simonsen, S.; Bratlie, A.; Thorsby, E.; Geiran, O., 1996:
HLA-DR matching reduces rejection rate in heart transplantation

Guerne, P.A., 1996:
HLA-DR molecular typing: diagnostic and prognostic value in beginning rheumatoid arthritis

Takeuchi, F.; Kawasugi, K.; Nabeta, H.; Mori, M.; Moritani, M.; Goto, M.; Matsuta, K.; Yamada, A.; Chihara, T.; Hanyu, T.; Murayama, T.; Yamamoto, S.; Murata, N.; Matsubara, T.; Itakura, M., 2000:
HLA-DR shared epitope in familial cases of Japanese rheumatoid arthritis

Tan, J.; Xie, T.; Xu, Q., 1997:
HLA-DR typing by standard serology and PCR-amplification with sequence-specific primers: a comparative study

Poli, F.; Scalamogna, M.; Mascaretti, L.; Nocco, A.; Sirchia, G., 1993:
HLA-DR typing of organ donors and allograft recipients by SSO typing: correlation with serotyping in the North Italy Transplant Program

Chen, D.F.; Endres, W.; Meyer, S.A.; Stangel, W., 1994:
HLA-DR typing using PCR-SSO with simultaneous hybridization of each dot blot membrane with a digoxigenin- and a biotin-marked probe

Ikeda, M.; Takahashi, H.; Yoshida, S., 1994:
HLA-DR+CD3+ and CD8+ cells are increased but CD4+CD45RA+ cells are reduced in the peripheral blood in human scrub typhus

Seidl, C.; Koch, U.; Brünnler, G.; Buhleier, T.; Frank, R.; Möller, B.; Markert, E.; Koller-Wagner, G.; Seifried, E.; Kaltwasser, J.P., 1998:
HLA-DR/DQ/DP interactions in rheumatoid arthritis

Rosloniec, E.F.; Whittington, K.B.; Zaller, D.M.; Kang, A.H., 2001:
HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen

Futami, S.; Aoyama, N.; Uchihashi, T.; Tamura, T.; Motosako, Y.; Morimoto, S.; Omoto, A.; Nakajima, T.; Okano, H.; Miyamoto, M., 1993:
HLA-DR2 DNA typing in Japanese ulcerative colitis

Kapustin, S.I.; Popova, T.I.; Lyschov, A.A.; Togo, A.V.; Abdulkadyrov, K.M.; Blinov, M.N., 1997:
HLA-DR2 Frequency Increase in Severe Aplastic Anemia Patients is Mainly Attributed to the Prevalence of DR15 Subtype

Selvaraj, P.; Kannapiran, M.; Reetha, A.M.; Uma, H.; Xavier, T.; Narayanan, P.R., 1997:
HLA-DR2 phenotype and plasma lysozyme, beta-glucuronidase and acid phosphatase levels in pulmonary tuberculosis

Wong, T.Yin.; Cruickshank, K.J.; Klein, R.; Klein, B.E.K.; Moss, S.E.; Palta, M.; Riley, W.J.; Maclaren, N.K.; Vadheim, C.M.; Rotter, J.I., 2002 :
HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy

Caraballo, L.; Martínez, B.; Jiménez, S.; Puerta, L., 1996:
HLA-DR3 is associated with the IgE immune responsiveness to a recombinant allergen from Blomia tropicalis (BT)

Auger, I.; Escola, J.M.; Gorvel, J.P.; Roudier, J., 1996:
HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins

Gough, A.; Faint, J.; Salmon, M.; Bacon, P.; Emery, P., 1995:
HLA-DR4 and career prospects in rheumatology: is there a link?

Kilpatrick, D.C., 2000:
HLA-DR4 and pre-eclampsia

Taurog, J.D., 2002:
HLA-DR4 and the spondyloarthropathies

Aisen, P.S.; Luddy, A.; Durner, M.; Reinhard, J.F.; Pasinetti, G.M., 1999:
HLA-DR4 influences glial activity in Alzheimer's disease hippocampus

Posthuma, E.F.; Falkenburg, J.H.; Apperley, J.F.; Gratwohl, A.; Hertenstein, B.; Schipper, R.F.; Oudshoorn, M.; Biezen, J.H.; Hermans, J.; Willemze, R.; Roosnek, E.; Niederwieser, D., 2000:
HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry

Wilson, C.; Tiwana, H.; Ebringer, A.; Cunningham, P.; Ettelaie, C., 1997:
HLA-DR4 restriction, molecular mimicry and rheumatoid arthritis

Reijonen, H.; Nejentsev, S.; Tuokko, J.; Koskinen, S.; Tuomilehto-Wolf, E.; Akerblom, H.K.; Ilonen, J., 1998:
HLA-DR4 subtype and -B alleles in DQB1*0302-positive haplotypes associated with IDDM. The Childhood Diabetes in Finland Study Group

Pile, K.; Gibson, K.; Jessop, J.; Camilleri, J.; Emberton, R.; Wordsworth, P., 1993:
HLA-DR4 subtyping by single-strand polymorphism analysis

Auger, I.; Roudier, J., 1997:
HLA-DR4, 70 kD heat shock proteins, and rheumatoid arthritis

Kapustin, S.I.; Popova, T.I.; Lyshchov, A.A.; Imyanitov, E.N.; Blinov, M.N.; Abdulkadyrov, K.M., 2001:
HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia

Mustafa, A.S.; Lundin, K.E.; Meloen, R.H.; Shinnick, T.M.; Coulson, A.F.; Oftung, F., 1996:
HLA-DR4-restricted T-cell epitopes from the mycobacterial 60,000 MW heat shock protein (hsp 60) do not map to the sequence homology regions with the human hsp 60

Anonymous, 2018:
A Medical Utopia

Fukuda, Y.; Kimura, A.; Hoshino, S.; Shintaku, S.; Sakaguchi, T.; Asahara, T.; Sakaki, M.; Sumimoto, R.; Tashiro, H.; Furukawa, M.; Ohdan, H.; Yoshida, T.; Dohi, K., 1996:
HLA-DR8 subtyping by polymerase chain reaction (PCR)-DNA conformation polymorphism (DCP) analysis: a simple and practical genotyping method

Cisse, A.; Chauffert, M.; Julier, C.; Chevenne, D.; Michel, S.; Trivin, F.; Diop, S.N.; Sidibe, E.H.; Sow, A.M., 1996:
HLA-DR:DQ genotypes and insulin-dependent diabetes in Senegal

Lai, S.P.; Ren, H.M.; Hu, H.T.; Li, S.B.; Lai, J.H.; Yan, C.X.; Zhang, H.B.; Zhao, J.H., 2000:
HLA-DRB alleles polymorphism in Han, Hui, Uygur and Tibetan populations in northwestern China

Gao, J.; Lin, Y.; Qiu, C., 2000:
HLA-DRB alleles polymorphism in susceptibility to asthma in Beijing Chinese

Slateva, K.; Elsner, H.A.; Albis-Camps, M.; Blasczyk, R., 2002:
HLA-DRB fluorotyping by dark quenching and automated analysis

Hashimoto, H.; Yamanaka, K.; Tokano, Y.; Iida, N.; Takasaki, Y.; Kabasawa, K.; Nishimura, Y., 1998:
HLA-DRB1 alleles and beta 2 glycoprotein I-dependent anticardiolipin antibodies in Japanese patients with systemic lupus erythematosus

Teller, K.; Budhai, L.; Zhang, M.; Haramati, N.; Keiser, H.D.; Davidson, A., 1996:
HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis: the "shared epitope" hypothesis may not apply

Drouet, M.; Delpuget-Bertin, N.; Vaillant, L.; Chauchaix, S.; Boulanger, M.D.; Bonnetblanc, J.M.; Bernard, P., 1998:
HLA-DRB1 and HLA-DQB1 genes in susceptibility and resistance to cicatricial pemphigoid in French Caucasians

Reviron, D.; André, M.; Cantaloube, J.F.; Biagini, P.; Chicheportiche, C.; Mercier, P., 1993:
HLA-DRB1 and HLA-DQB1 polymorphism in Algerians from Algiers

Ma, J.J.; Nishimura, M.; Mine, H.; Saji, H.; Ohta, M.; Saida, K.; Ozawa, K.; Kawakami, H.; Saida, T.; Uchiyama, T., 1999:
HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis

Huang, J.L.; Shaw, C.K.; Lee, A.; Lee, T.D.; Chou, Y.H.; Kuo, M.L., 2002:
HLA-DRB1 antigens in Taiwanese patients with juvenile-onset systemic lupus erythematosus

Amoli, M.M.; Thomson, W.; Hajeer, A.H.; Garcia-Porrua, C.; Lueiro, M.; Ollier, W.E.; Gonzalez-Gay, M.A., 2002:
HLA-DRB1 associations in biopsy proven erythema nodosum

al-Ansari, A.S.; Hajeer, A.H.; Garcia-Porrua, C.; Thomson, W.; Ollier, W.E.; Gonzalez-Gay, M.A., 2001:
HLA-DRB1 associations in systemic lupus erythematosus patients from northwest Spain

Jia, Z.J.; Pan, D.J.; Fu, Y.G.; Chen, W.M.; Liu, Z.H.; Lin, J.H.; Zhu, Y.F.; Chen, R.X.; Fu, Z.Y.; Zhou, D.M.; Xu, A.L., 2002:
HLA-DRB1 gene polymorphism of Naxi ethnic group of Yunnan Province, China and its ethnological evolution analysis

Reveille, J.D.; Alarcón, G.S.; Fowler, S.E.; Pillemer, S.R.; Neuner, R.; Clegg, D.O.; Mikhail, I.S.; Trentham, D.E.; Leisen, J.C.; Bluhm, G.; Cooper, S.M.; Duncan, H.; Tuttleman, M.; Heyse, S.P.; Sharp, J.T.; Tilley, B., 1996:
HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis

Kong, K.F.; Yeap, S.S.; Chow, S.K.; Phipps, M.E., 2002:
HLA-DRB1 genes and susceptibility to rheumatoid arthritis in three ethnic groups from Malaysia

Tian, X.; Jiang, M.; Qiu, C., 1999:
HLA-DRB1 genes in 5 rheumatic disease multi-case families

Listing, J.; Rau, R.; Müller, B.; Alten, R.; Gromnica-Ihle, E.; Hagemann, D.; Zink, A., 2000:
HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. Berlin Collaborating Rheumatological Study Group

Fries, J.F.; Wolfe, F.; Apple, R.; Erlich, H.; Bugawan, T.; Holmes, T.; Bruce, B., 2002:
HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias

Sechkin, A.V.; Dolbin, A.G.; Filiptsev PYa; Sokolovsky, A.S.; Boldyreva, M.N.; Trofimov DYu; Dmitrieva, N.G.; Benenson, L.I.; Plavunov, N.F.; Akhmetshin, R.B.; Khaitov, R.M.; Alexeev, L.P., 1998:
HLA-DRB1 genotyping in prospective selection of kidney donors

Auger, I.; Toussirot, E.; Roudier, J., 1999:
HLA-DRB1 motifs and heat shock proteins in rheumatoid arthritis

Liu, L.M.; Liang, J.; Wang, B.J.; Ding, M.; Li, J.P.; Li, C.M.; Xiao, Y.Z.; Jia, J.T., 2003:
HLA-DRB1 typing by PCR-sequence specific primers for paternity determination

Poli, F.; Mascaretti, L.; Scalamogna, M.; Crespiatico, L.; Cagni, N.; Sioli, V.; Sirchia, G., 1997:
HLA-DRB1 typing does not prolong cold ischemia time and affects outcome in cadaver kidney transplantation

D'Amato, M.; Picardi, A.; Menna, T.; D.S.mma, C.; Ariano, R.; di Pietro, A.; Charron, D.; Maggi, E.; Matricardi, P.; Plebani, A.; Poto, S.; Testa, G.; Sacerdoti, G.; Ruffilli, A., 2000:
HLA-DRB1* and allergy to Parietaria: linkage and association analyses

Stavropoulos, C.; Spyropoulou, M.; Koumantaki, Y.; Kappou, I.; Kaklamanis, P.V.; Linos, A.; Giziaki, E.; Kaklamani, E., 1997:
HLA-DRB1* genotypes in Greek rheumatoid arthritis patients: association with disease characteristics, sex and age at onset

Guis, S.; Pellissier, J-François.; Nicoli, Fçois.; Reviron, D.; Mattei, J-Pierre.; Gherardi, R.K.; Pelletier, J.; Kaplanski, G.; Figarella-Branger, D.; Roudier, J., 2002:
HLA-DRB1*01 and macrophagic myofasciitis

Shankarkumar, U.; Ghosh, K.; Badakere, S.S.; Mohanty, D., 2002:
HLA-DRB1*03 and DQB1*0302 associations in a subset of patients severely affected with systemic lupus erythematosus from western India

Bouma, G.; Poen, A.C.; García-González, M.A.; Schreuder, G.M.; Felt-Bersma, R.J.; Meuwissen, S.G.; Pena, A.S., 1998:
HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease

Gunnarsson, I.; Ringertz, B.; Bratt, J.; Sundelin, B., 2001:
HLA-DRB1*0301 and DQA1*0501 in RA

Donner, H.; Seidl, C.; Van der Auwera, B.; Braun, J.; Siegmund, T.; Herwig, J.; Weets, I.; Usadel, K.H.; Badenhoop, K., 2000:
HLA-DRB1*04 and susceptibility to type 1 diabetes mellitus in a German/Belgian family and German case-control study. The Belgian Diabetes Registry

Bouwens-Rombouts, A.G.; Verduyn, W.; Versluis, L.F.; Schreuder, G.M.; Tilanus, M.G.; Giphart, M., 1996:
HLA-DRB1*04 high resolution typing

Gonzalez-Gay, M.A.; Garcia-Porrua, C.; Hajeer, A.H.; Dababneh, A.; Ollier, W.E., 2000:
HLA-DRB1*04 may be a marker of severity in giant cell arteritis

Jee, S.H.; Tsai, T.F.; Tsai, W.L.; Liaw, S.H.; Chang, C.H.; Hu, C.Y., 1999:
HLA-DRB1*0701 and DRB1*1401 are associated with genetic susceptibility to psoriasis vulgaris in a Taiwanese population

Reviron, D.; Dormoy, A.; André, M.; Froelich, N.; Roudier, J.; Tongio, M.M.; Mercier, P., 1997:
HLA-DRB1*1608: a new HLA-DRB1*16 allele with a short DRB1*03 sequence

Molnar-Gabor, E.; Endreffy, E.; Rozsasi, A., 2000:
HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis

Kotalová, R.; Vraná, M.; Dobrovolná, M.; Nevoral, J.; Loudová, M., 2002:
HLA-DRB1/DQA1/DQB1 alleles and haplotypes in Czech children with celiac sprue

Smikie, M.F.; Pascoe, R.W.; Barton, E.; Morgan, O.; Christian, N.; Dowe, G.; Roye-Green, K.; Bailey, V.; James, O., 2002:
HLA-DRB3*0101 is associated with Graves' disease in Jamaicans

Martinez-Laso, J.; Gomez-Casado, E.; Arnaiz-Villena, A., 2002:
HLA-E and HLA-G typing

Steffensen, R.; Christiansen, O.B.; Bennett, E.P.; Jersild, C., 1999:
HLA-E polymorphism in patients with recurrent spontaneous abortion

Wainwright, S.D.; Biro, P.A.; Holmes, C.H., 1999:
HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern

Matte, C.; Lacaille, J.; Zijenah, L.; Ward, B.; Roger, M., 2001:
HLA-G and HLA-E polymorphisms in an indigenous African population. The ZVITAMBO Study Group

Carosella, E.D.; Paul, P.; Moreau, P.; Rouas-Freiss, N., 2001:
HLA-G and HLA-E: fundamental and Pathophysiological aspects

Carosella, E.D.; Paul, P.; Moreau, P.; Rouas-Freiss, N., 2001:
HLA-G and HLA-E: fundamental and pathophysiological aspects

L.B.uteiller, P.; Mallet, V., 1997:
HLA-G and pregnancy

Davies, B.; Hiby, S.; Gardner, L.; Loke, Y.W.; King, A., 2001:
HLA-G expression by tumors

Goldman-Wohl, D.S.; Ariel, I.; Greenfield, C.; Hanoch, J.; Yagel, S., 2000:
HLA-G expression in extravillous trophoblasts is an intrinsic property of cell differentiation: a lesson learned from ectopic pregnancies

Rabreau, M.; Rouas-Freiss, N.; Landi, M.; L.D.nff, C.; Carosella, E.D., 2001:
HLA-G expression in trophoblast cells is independent of embryonic development

Aldrich, C.L.; Stephenson, M.D.; Karrison, T.; Odem, R.R.; Branch, D.W.; Scott, J.R.; Schreiber, J.R.; Ober, C., 2001:
HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage

Hunt, J.S.; Petroff, M.G.; Morales, P.; Sedlmayr, P.; Geraghty, D.E.; Ober, C., 2001:
HLA-G in reproduction: studies on the maternal-fetal interface

Rouas-Freiss, N.; LeMaoult, Jël.; Moreau, P.; Dausset, J.; Carosella, E.D., 2002:
HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?

van der Ven, K.; Pfeiffer, K.; Skrablin, S., 2000:
HLA-G polymorphisms and molecule function--questions and more questions--a review

Ober, C.; Aldrich, C.L., 1998:
HLA-G polymorphisms: neutral evolution or novel function?

Bulmer, J.N.; Cioni, R.; Bussani, C.; Cirigliano, V.; Sole, F.; Costa, C.; Garcia, P.; Adinolfi, M., 2003:
HLA-G positive trophoblastic cells in transcervical samples and their isolation and analysis by laser microdissection and QF-PCR

Mellor, A.; Zhou, M.; Conway, S.J.; Munn, D., 1999:
HLA-G transgenic mice

Menier, C.; Riteau, B.; Dausset, J.; Carosella, E.D.; Rouas-Freiss, N., 2001:
HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival

Paul, P.; Rouas-Freiss, N.; Moreau, P.; Cabestre, F.A.; Menier, C.; Khalil-Daher, I.; Pangault, C.; Onno, M.; Fauchet, R.; Martinez-Laso, J.; Morales, P.; Villena, A.A.; Giacomini, P.; Natali, P.G.; Frumento, G.; Ferrara, G.B.; McMaster, M.; Fisher, S.; Schust, D.; Ferrone, S.; Dausset, J.; Geraghty, D.; Carosella, E.D., 2001:
HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression

Rabreau, M.; de Vedrines, C.H., 1999:
HLA-G-related repeat abortions with histological characteristics of organ rejection

Riteau, B.; Rouas-Freiss, N.; Menier, C.; Paul, P.; Dausset, J.; Carosella, E.D., 2001:
HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis

Dausset, J.; Carosella, E.D., 1999:
HLA-G: a new opening for HLA

Carosella, E.D.; Rouas-Freiss, N.; Paul, P.; Dausset, J., 1999:
HLA-G: a tolerance molecule from the major histocompatibility complex

Paul, P.; Rouas-Freiss, N.; Carosella, E.D., 1999:
HLA-G: a tolerance molecule implicated in the escape of tumors from immunosurveillance

Carosella, E.D., 2000:
HLA-G: fetomaternal tolerance

Le Discorde, M.; Moreau, P.; Rouas-Freiss, N.; Carosella, E., 2002:
HLA-G: immune tolerance in normal and pathological physiology

L.Bouteiller, P., 1998:
HLA-G: on the track of immunological functions

Beutler, E.; Gelbart, T., 1997:
HLA-H mutations in the Ashkenazi Jewish population

Tarassi, K.; Carthy, D.; Papasteriades, C.; Boki, K.; Nikolopoulou, N.; Carcassi, C.; Ollier, W.E.; Hajeer, A.H., 1998:
HLA-TNF haplotype heterogeneity in Greek SLE patients

Tan, J.; Tang, X.; Zhou, Y., 2002:
HLA-amino acid residue matching in organ transplantation

Tan, J.; Tang, X.; Xie, T., 2001:
HLA-amino acid residue matching standard and immunogenic response

Flesch, B.K.; Philipp, M.; Cassens, U.; Neppert, J., 2002:
HLA-antibody testing: the immune phagocytosis inhibition test is superior to the PRA-STAT and NIH lymphocytotoxic test with respect to specificity

Maharaj, B.; Khedun, S.M.; Hammond, M.G., 1998:
HLA-antigens in black patients with hepatocellular carcinoma

Fukui, M.; Nakamura, N.; Nakano, K.; Kajiyama, S.; Matsuo, S.; Obayashi, H.; Ohta, M.; Shigeta, M.; Shigeta, H.; Kitagawa, Y.; Kondo, M., 2001:
HLA-associated cellular response to GAD in type 2 diabetes with antibodies to GAD

Zaitz, C.; Campbell, I.; Moraes, J.R.; Moraes, M.E.; Gouvea, C.; Romero, M.; Gouvea, N.; Sadahiro, A.; Chamone, D.; Dorlhiac, P., 1996:
HLA-associated susceptibility to chronic onychomycosis in Brazilian Ashkenazic Jews

Procházková, J.; Bártová, J.; Ivasková, E.; Kupková, L.; Sterzl, I.; Stejskal, V.D., 2001:
HLA-association in patients with intolerance to mercury and other metals in dental materials

Knoll, M.R.; Rohr, G.; Singer, M.V., 1993:
HLA-association of lymphocytic colitis: indications for an independent disease entity?

Birol, A.; Anadolu, R.Yavuzer.; Tutkak, Hüseyin.; Gürgey, E., 2002:
HLA-class 1 and class 2 antigens in Turkish patients with pemphigus

Kilpatrick, D.C., 1996:
HLA-dependent TNF secretory response may provide an immunogenetic link between pre-eclampsia and type 1 diabetes mellitus

Krensky, A.M.; Clayberger, C., 1997:
HLA-derived peptides as novel immunosuppressives

Featherstone, C., 1996:
HLA-derived peptides in clinical trial for kidney allografts

Agarwal, S.; Singh, N.; Naik, S., 1993:
HLA-disease association at the molecular level

Peddi, V.R.; Weiskittel, P.; Alexander, J.W.; Woodle, E.S.; First, M.R., 2001:
HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival

Michallet, M.; Archimbaud, E.; Bandini, G.; Rowlings, P.A.; Deeg, H.J.; Gahrton, G.; Montserrat, E.; Rozman, C.; Gratwohl, A.; Gale, R.P., 1996:
HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry

Watanabe, T.; Takaue, Y.; Kawano, Y.; Koike, K.; Kikuta, A.; Imaizumi, M.; Watanabe, A.; Eguchi, H.; Ohta, S.; Horikoshi, Y.; Iwai, A.; Makimoto, A.; Kuroda, Y., 2002:
HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents

de Mattos, A.M.; Bennett, W.M.; Barry, J.M.; Norman, D.J., 1999:
HLA-identical sibling renal transplantation--a 21-yr single-center experience

Nishimura, Y., 1994:
HLA-linked susceptibility to intractable vasculitis syndrome

Cisse, A.; Chevenne, D.; Chauffert, M.; Ndiaye, M.R.; Wade, A.; Trivin, F., 1998:
HLA-markers and diabetic retinopathy in the Senegalese population

Eckman, M.H.; Sonnenberg, F.A.; Jacoby, I.; Pauker, S.G., 1985:
HLA-matched donor registries for bone marrow transplants. A decision analysis

Matsushita, S., 1999:
HLA-peptide complex and immunity-related diseases

Sirchia, G., 1996:
HLA-reduced platelets to overcome platelet refractoriness: can lemons help?

Zanni, M.P.; von Greyerz, S.; Schnyder, B.; Brander, K.A.; Frutig, K.; Hari, Y.; Valitutti, S.; Pichler, W.J., 1998:
HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes

Moretta, A.; Bottino, C.; Millo, R.; Biassoni, R., 1999:
HLA-specific and non-HLA-specific human NK receptors

Frolov, V.M.; Iushchuk, N.D.; Gaĭdash, I.S.; Peresadin, N.A., 1993:
HLA-system antigens in patients with food poisonings caused by opportunistic bacteria

Maccario, R.; Revello, M.G.; Comoli, P.; Montagna, D.; Locatelli, F.; Gerna, G., 1993:
HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes

Rubio Vela, T.; Gaztélu Contín, M.T.; Alonso Martínez, J.L., 1999:
HLA: past, present and future

Duquesnoy, R.J., 2001:
HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients

Martin, P.J.; Gooley, T.; Anasetti, C.; Petersdorf, E.W.; Hansen, J.A., 1999 :
HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling

Karabay-Bayazit, A.; Noyan, A.; Bayazit, Y.; Ozel, A.; Anarat, A., 2001:
HLAs in children with minimal change disease and other types of nephrotic syndrome in the southern part of Turkey

Henter, J.I.; Aricò, M.; Egeler, R.M.; Elinder, G.; Favara, B.E.; Filipovich, A.H.; Gadner, H.; Imashuku, S.; Janka-Schaub, G.; Komp, D.; Ladisch, S.; Webb, D., 1997:
HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society

Pandian, P.; Kannan, M., 1993:
HLL -- the partaker of the population control programmes

Anonymous, 1995:
HLS (Hospital Laundry Service) opens off-site sterile pack plant

Anonymous, 1986:
HLTV-III test; confidentiality; informed consent

Quiros, J.A., 2000:

Hacène, H.; Kebir, K.; Othmane, D.S.; Lefebvre, G., 1994:
HM17, a new polyene antifungal antibiotic produced by a new strain of Spirillospora

Kirchheimer, B., 1999:
HMA (Health Management Associates, Inc.) shares plunge on earnings news

Kostner, G.M., 1999:
HMA CoA reductase inhibitors

Greene, J., 1995:
HMA backs out of Cape Coral purchase

Lutz, S., 1995:
HMA reaches further into rural markets

Brichta, D., 1978:
HMA: a money back guarantee

Laforga, J.B.; Aranda, F.I., 1994:
HMB-45 reactivity in sustentacular cells of paragangliomas

Skelton, H.G.; Maceira, J.; Smith, K.J.; McCarthy, W.F.; Lupton, G.P.; Graham, J.H., 1998:
HMB45 negative spindle cell malignant melanoma

Zamecnik, M.; Michal, M., 2003:
HMB45+ hyalinized epithelioid tumor of the uterus is linked to epithelioid leiomyoma rather than to PEC-omas

Boldrini, R.; Innocenzi, D.; Panetta, C.; Bosman, C., 2000:
HMB45-negative, clear-cell amelanotic melanoma with aberrant melanosomes

Shirsat, N.V., 2000:
HMBA inhibits growth and induces differentiation of astrocytes from neonatal rat brain

Arnold, L.D., 1993:
HMBANA guidelines on breast pumps and human milk storage and handling

Burda, D., 1992:
HME dealer files second suit against Fla. hospital

Lutz, S., 1988:
HME dealers await changes in reimbursement policy

Wagner, L., 1990:
HME fee variations prompt restraint talk

Anonymous, 1988:
HME firms seek accreditation, view it as key to industry norm

Lutz, S.; Wagner, M., 1991:
HME groups discuss merger

Kulikova, O.G.; Reĭkhardt, B.A., 1996:
HMG 14--a physiological substrate for casein kinase NII of neuronal chromatin

Fruchart, J-Charles.; Duriez, P., 2002:
HMG CoA reductase inhibitors and PPAR-alpha activators: are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials?

Poullis, M., 1999:
HMG CoA reductase inhibitors and cardiac surgery

Thompson, G.R., 1993:
HMG CoA reductase inhibitors and diet in familial hypercholesterolaemia

Downs, J.R.; Oster, G.; Santanello, N.C., 1993:
HMG CoA reductase inhibitors and quality of life

Soma, M.R.; Donetti, E.; Parolini, C.; Mazzini, G.; Ferrari, C.; Fumagalli, R.; Paoletti, R., 1993:
HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits

Huynh, T.; Cordato, D.; Yang, F.; Choy, T.; Johnstone, K.; Bagnall, F.; Hitchens, N.; Dunn, R., 2002:
HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions

Schilham, M.W.; Clevers, H., 1998:
HMG box containing transcription factors in lymphocyte differentiation

Zhao, Y.; Cheng, W.; Gibb, C.L.; Gupta, G.; Kallenbach, N.R., 1996:
HMG box proteins interact with multiple tandemly repeated (GCC)n (GGC)m DNA sequences

Yoshida, M., 1996:
HMG box proteins: general architectural elements in the assembly of active transcription complex

Decoville, M.; Giraud-Panis, M.J.; Mosrin-Huaman, C.; Leng, M.; Locker, D., 1999:
HMG boxes of DSP1 protein interact with the rel homology domain of transcription factors

Klag, M.J., 2000:
HMG coenzyme A reductase inhibitors: good news and bad news

Check, J.H., 2001:
HMG is possibly superior to recombinant FSH for IVF

Abraham, E.; Arcaroli, J.; Carmody, A.; Wang, H.; Tracey, K.J., 2000:
HMG-1 as a mediator of acute lung inflammation

Grigorov, I.; Milosavljević, T.; Cvetković, I.; Petrović, M., 2002:
HMG-1 as regulatory trans-acting protein in the acute phase-induced expression of the rat liver haptoglobin gene

Yang, H.; Wang, H.; Tracey, K.J., 2001:
HMG-1 rediscovered as a cytokine

Angelova, A.; Borissova, Z.; Avramova, F.; Simeonova, V.; Stambolova, M., 1993:
HMG-2 protein in developing rat brain cells

Morishita, R.; Tomita, N.; Ogihara, T., 2002:
HMG-Co A reductase inhibitors in the treatment of cardiovascular diseases: stabilization of coronary artery plaque

Ozaki, H.; Shirai, K., 2001:
HMG-CoA reductase

Manns, D., 1999:
HMG-CoA reductase antagonists in review

Kandoussi, A.; Martin, Fçois.; Hazzan, M.; Noël, C.; Fruchart, J-Charles.; Staels, B.; Duriez, P., 2002:
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells

Endres, M.; Laufs, U., 1998:
HMG-CoA reductase inhibitor and risk of stroke

Jacobs, M.B., 1994:
HMG-CoA reductase inhibitor therapy and peripheral neuropathy

Wanner, C., 1996:
HMG-CoA reductase inhibitor treatment in renal insufficiency

Tsujita, Y., 1993:
HMG-CoA reductase inhibitor, pravastatin

Sparks, D.L.; Connor, D.J.; Browne, P.J.; Lopez, J.E.; Sabbagh, M.N., 2002:
HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier

Dimmeler, S.; Aicher, A.; Vasa, M.; Mildner-Rihm, C.; Adler, K.; Tiemann, M.; Rütten, H.; Fichtlscherer, S.; Martin, H.; Zeiher, A.M., 2001:
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

Ahmed, H.A.; Jazrawi, R.P.; Northfield, T.C., 1996:
HMG-CoA reductase inhibitors and bile lithogenicity: cholesterol supersaturation or nucleation defect?

Pía Iglesias, G.; Fernández Fernández, F.J.; Ameneiros Lago, E.; Sesma Sánchez, P., 2001:
HMG-CoA reductase inhibitors and sexual dysfunction

Windler, E., 1996:
HMG-CoA reductase inhibitors for prevention and treatment of coronary heart disease. Effective reduction of cardiac events and mortality

Wojakowski, W.; Gmiński, J., 2000:
HMG-CoA reductase inhibitors in prevention of cardiovascular diseases: new mechanisms, aspects and trials

Windler, E.; Greten, H., 1993:
HMG-CoA reductase inhibitors in therapy of disorders of lipid metabolism

Iimura, O.; Vrtovsnik, F.; Terzi, F.; Friedlander, G., 1997:
HMG-CoA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture

Skaletz-Rorowski, A.; Lutchman, M.; Kureishi, Y.; Lefer, D.J.; Faust, J.R.; Walsh, K., 2002:
HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells

Anonymous, 1997:
HMG-CoA reductase inhibitors reduce stroke risk, total mortality

Valantine, H.A.; Schroeder, J.S., 1997:
HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms?

da Silva, P.M., 1999:
HMG-CoA reductase inhibitors: a brief review of their pharmacological properties and clinical efficacy in cardiovascular disease

Rossen, R.D., 1997:
HMG-CoA reductase inhibitors: a new class of anti-inflammatory drugs?

Fujita, R.; Matsushima, T., 2000:
HMG-CoA reductase inhibitors: anti-atherosclerotic effects other than lipid-lowering

Beaird, S.L., 2000:
HMG-CoA reductase inhibitors: assessing differences in drug interactions and safety profiles

Gotto, A.M., 1996:
HMG-CoA reductase inhibitors: issues in assessing their benefits in coronary heart disease

Dimitroulakos, J.; Yeger, H., 1996:
HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells

Petras, S.F.; Lindsey, S.; Harwood, H.J., 1998:
HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells

Oyama, T.; Shirai, K., 2001:
HMG-CoA synthase

Dolde, C.E.; Mukherjee, M.; Cho, C.; Resar, L.M.S., 2002:
HMG-I/Y in human breast cancer cell lines

Thomas, J.O., 2001:
HMG1 and 2: architectural DNA-binding proteins

Chikhirzhina, E.V.; Polianichko, A.M.; Skvortsov, A.N.; Kostyleva, E.I.; Houssier, C.; Vorob'ev, V.I., 2002:
HMG1 domains: the victims of circumstance

Gallardo, Gán.; López-Blanco, Félix.; Ruiz de Galarreta, C.M.; Fanjul, L.F., 2002:
HMGCoA reductase inhibition partially mediates tumor necrosis factor alpha-induced apoptosis in human U-937 and HL-60 cells

Tallini, G.; Dal Cin, P., 1999:
HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors

Rommel, B.; Rogalla, P.; Jox, A.; Kalle, C.V.; Kazmierczak, B.; Wolf, J.; Bullerdiek, J., 1997:
HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells

Roberts, R.; Mitchell, J., 1998:
HMI education for HIMs

Bègue, B.; Sarnacki, S.; le Deist, F.; Buc, H.; Gagnon, J.; Méo, T.; Cerf-Bensussan, N., 1995:
HML-1, a novel integrin made of the beta 7 chain and of a distinctive alpha chain, exerts an accessory function in the activation of human IEL via the CD3-TCR pathway

Anonymous, 1987:
HMM drug price index advances at 4% annual rate

Anonymous, 1990:
HMM price watch

Anonymous, 1990:
HMM price watch. Purchasing managers' index continues 3-month drop, falling 6% to 44.4 in September from 47.0

Anonymous, 1990:
HMM price watch. Purchasing managers' index continues to decline, falling 5% to 41.3 in November

Anonymous, 1990:
HMM price watch. Purchasing managers' index continues to drop, falling .8% to 47.0 in August from 47.7 in July

Anonymous, 1989:
HMM price watch. Purchasing managers' index hits 2-year low; prices up on aluminum, plastics and paper

Anonymous, 1990:
HMM price watch. Purchasing managers' index inches over 50 to 50.2 in April, up from 48.8 last month

Anonymous, 1990:
HMM price watch. Purchasing managers' index keeps on climbing, reaching 51.1 in June from 50.7 in May

Anonymous, 1990:
HMM price watch. Purchasing managers' index reverses 3-month climb, drops to 47.4 in July from 51.1 in June

Anonymous, 1990:
HMM price watch. Purchasing managers' index still on upward climb from 50.2 in April to 50.7 in May

Anonymous, 1990:
HMM pricing index. Drug indexes down .6% from first quarter

Anonymous, 1989:
HMM pricing index. Med-surg index follows x-ray film prices up

Anonymous, 1990:
HMM pricing index. Med-surg prices up 0.8% in the second quarter

Anonymous, 1989:
HMM pricing index. Twelve of 21 indexes down in last two years

Anonymous, 1991:
HMM pricing index/price watch

Bateman, A.; Haft, D.H., 2002:
HMM-based databases in InterPro

Yokokura, H.; Okada, Y.; Terada, O.; Hidaka, H., 1996:
HMN-709, a chlorobenzenesulfonamide derivative, is a new membrane-permeable calmodulin antagonist

Duke, S., 2000:
HMNo: the name of this practice says it all

Moore, G.T., 1989:
HMO Britannia: will she waive the rules?

Kenkel, P.J., 1988:
HMO CEOs receive average 12.3% raise

Anonymous, 1978:
HMO Illinois sees tremendous growth this year

Thompson, J.M.; Howard, J.E., 2001:
HMO Web sites: what do they tell consumers?

Saxton, J.; Flanagan, G.S., 2000:
HMO accountability in New Jersey

Morrissey, J., 1995:
HMO acquisition in N.H. gets antitrust OK--with strings

Anonymous, 2001:
HMO administrative expense benchmarks help providers negotiate better rates

Anonymous, 1986:
HMO affirms abortion coverage

Anonymous, 1975:
HMO amendments pass House; Senate action not set

Hu, T.W.; Sullivan, S.D.; Scheffler, R.M., 1991:
HMO and PPO growth and hospital utilization and payment: a recursive model

Druehl, C.P., 1997:
HMO and insurance insolvency: the benefits and detriments of a federal system

Brazil, J.H., 1985:
HMO appeal. Could you get more care for your cash?

Kenkel, P.J., 1988:
HMO appeals to patients' needs

McCormack, J., 1997:
HMO automation strategies

Huff, C., 1998:
HMO backlash. Doctors who just say no

Pauly, M.V.; Hillman, A.L.; Furukawa, M.F.; McCullough, J.S., 2001:
HMO behavior and stock market valuation: what does Wall Street reward and punish?

Anonymous, 1994:
HMO care not much different from fee-for-service care, study finds

Cain, C., 1984:
HMO chains grow fast, but hospitals could edge into their market

Lewis, S.A.; Sorel, K.L.; Smith, J.C., 1998:
HMO chiropractic referrals: a nurse triage approach

Anonymous, 1980:
HMO collapses after physicians withdraw

Cave, D.G., 1989:
HMO community rating by class: employers and HMOs need to collect health status information

Early, P., 1991:
HMO competes with cost-cutting and coyotes

Luehrs, J.; Hanson, D., 1984:
HMO competition for Wisconsin's state employees

Anonymous, 1980:
HMO competition in Minneapolis-St. Paul reduces hospitalization, cuts costs, improves services

Knazik, S.; Ledwith, C.; Saulys, A., 1996:
HMO confrontations

Anonymous, 2000:
HMO consolidation: a threat to network integration?

Feldman, R.D.; Wholey, D.R.; Christianson, J.B., 1999:
HMO consolidations: how national mergers affect local markets

Jaklevic, M.C., 1995:
HMO contests hospital control of docs

Wittgen, J.S., 1990:
HMO contracting presents SNFs with benefits, opportunities

Brown, C.A.; Reiss, J.B., 2000:
HMO contracting strategies: protecting the provider's interests

McCann, R.W., 1982:
HMO contracting: a new Medicaid opportunity results from '81 Budget Reconciliation Act changes to Social Security Act

Astle, S.; Roth, R., 1987:
HMO contracting: know your costs

Conklin, M., 1995:
HMO cuts premature baby rate in half

Fink, R., 1998:
HMO data systems in population studies of access to care

Lapham, S.C.; Montgomery, K.A.; Hoy, W.E., 1990:
HMO databases: fertile ground for epidemiological research

Terry, K., 1994:
HMO deals that give you more money for more risk

Weissenstein, E., 1996:
HMO demonstration project may face delay

Brill, W.A., 1996:
HMO dentistry (capitation): how to profit and be ethical at the same time

Bosch, S.J.; Deuschle, K.W., 1993:
HMO development in an academic medical center: the rise and fall of a prepaid health program in New York city

Coutinho, A.; Hunter, H., 1984:
HMO development in the U.S. and Brazil

Goldfarb, S.D.; Duncan, B.S.; Dans, P.E.; Sloan, A.S., 1999:
HMO direct costs and health care resources use after implementation of a monthly limit on sumatriptan

Anonymous, 1999:
HMO disputes. When patients and HMOs disagree

Herring, M.E.; Erde, E.L., 1994:
HMO doctor--for nonsmokers only?

Anonymous, 2002:
HMO drug formulary access increases for COX-2s

McCann, R.W., 1984:
HMO drug sales exempt from antitrust statute

Klinger, A.D., 1990:
HMO employees--including doctors--must unionize

Fischer, L.A., 1987:
HMO encroachment. The Palm Beach County Medical Society's response

DeFrancesco, L.B., 2002:
HMO enrollees experience fewer disparities than other insured populations: for educational factors, HMOs help "close the gap"

Anonymous, 2001:
HMO enrollment declines, but capitation holding its own

Richman, D., 1985:
HMO enrollment heading higher, but experts disagree on how fast

Doherty, J.F., 1983:
HMO enrollment rises as involvement in alternative delivery systems increases

Kenkel, P.J., 1991:
HMO enrollment rises nearly 5% to 36.5 million in 1990--GHAA

Anonymous, 2002:
HMO enrollment stabilizes, but number of HMOs continues to shrink

Kertesz, L., 1995:
HMO enrollment up 12% nationally

Tatge, M., 1985:
HMO enrollment up 26.7% to 1.68 million

Bendix, J., 1981:
HMO enrollment will increase 12% in '82

Anonymous, 2001:
HMO enrollment, penetration rates reveal surprises

Kertesz, L., 1996:
HMO execs bring in big pay--studies

Kertesz, L., 1996:
HMO execs team up for public image forum

Kenkel, P.J., 1988:
HMO executives expected to get bigger raises than leaders in other industries

Rauber, C., 1999:
HMO exodus continues

Quattlebaum, B., 1996:
HMO expenses

Jacks, B.W., 1983:
HMO exposures. One plan structure could trigger liability suits

Tetlow, K., 1996:
HMO facility. Kaiser Permanente TownPark, Cobb County, Georgia

Shouldice, R.G., 1990:
HMO facts and fictions

Weyrauch, K.F.; Boiko, P.; Feeny, D., 1995:
HMO family physicians: men and women differ in their work

Mitchell, C., 1998:
HMO figures more troubling news for poor. Not enough of budgeted money appears to be filtering down to patient care

Rose, J.R., 1997:
HMO finances. The cost of cutting costs is beginning to hurt

Coyne, J.S.; Hansen, D.J., 1992:
HMO financial solvency: should hospitals be concerned?

Gardner, J., 2000:
HMO finger-pointing abounds after defeat

Anonymous, 1997:

Staver, S., 1980:
HMO for senior citizens draws fire from MDs

Horn, S.D., 1996:
HMO formularies and care costs

Kertesz, L., 1995:
HMO groups plan counterpunch to media criticism

Escarce, J.J.; Polsky, D.; Wozniak, G.D.; Kletke, P.R., 2000:
HMO growth and the geographical redistribution of generalist and specialist physicians, 1987-1997

Anonymous, 1996:
HMO growth shows no signs of slowing

Duffy, D.A., 1985:
HMO growth still predicted

Anonymous, 1998:
HMO growth trends

Cushing, B., 1980:
HMO growth: incentive plan shows signs of success

Henchbarger, T.L., 1986:
HMO health education enters the computer age

Kirchheimer, B., 1999:
HMO hits W.Va. hospital's bottom line

Matlock, M.A., 1981:
HMO hopes to deliver maternity cost savings

Snyder, J.D.; Bale, C., 1980:
HMO in Congress' backyard is bailed out

Shalowitz, M.; Pollack, B.A.; Shalowitz, J.I., 1983:
HMO income: what it takes to make it

Baldwin, M.F., 1985:
HMO industry leaders want HCFA to tone down its peer review plans

Igou, K.D., 1986:
HMO information systems

Stocker, T., 1986:
HMO information systems--filling the gaps

Paperny, D.M.; Maeser, J.D.; Artz, K.; Stroh, M.J.; Jackson, L.; Cohen, K.; Lancaster, M.S.; Heyer, A.L.; Clevenson, D.S., 1991:
HMO innovations. Video-enhanced medical advice; senior zoo walkers; Group Health Resource Line; enhancing health education programs through desktop publishing; home health beat; innovative school health partnership

Anonymous, 1999:
HMO insolvencies: physicians left holding the bag

Wallace, C., 1986:
HMO is targeting small employers to fuel expansion throughout state

Martinsons, J., 1989:
HMO lawsuits are sparking liability concerns

Maurer, R.S., 1999:
HMO legislative proposals. Should suits be permitted

Adams, A., 2000:
HMO liability

Briskin, A.; Hinkley, G., 2000 :
HMO liability battleground moving to courts, statehouse

Anonymous, 2001:
HMO liability exposure expanded by Illinois Supreme Court decision

Terry, B.X., 2000:
HMO liability for the use of financial incentive arrangements in the provision of health care

Diamond, F., 1999:
HMO liability: how will it affect physicians? Come on in! The water fine!

Anonymous, 2001:
HMO losses may haunt 2001 contract negotiations

Kertesz, L., 1997:
HMO makeover. Are managed care's efforts to overhaul its image too little, too late?

Morrissey, J., 1994:
HMO makes case for NCQA in Washington

Hansen, E., 2001:
HMO malpractice: have the floodgates opened?

Veit, H.R., 1983:
HMO management in an entrepreneurial health care system

Baker, L.C.; Cantor, J.C.; Long, S.H.; Marquis, M.S., 2000:
HMO market penetration and costs of employer-sponsored health plans

Wholey, D.R.; Christianson, J.B.; Engberg, J.; Bryce, C., 1998:
HMO market structure and performance: 1985-1995

Devita, A.J.; Pearson, D.A., 1982:
HMO marketing: determining the importance of facility location in consumer choice

Holt, M., 1987:
HMO marketing: the Cadillac and the Chevy

Friedman, B.; Kane, R.L., 1993:
HMO medical directors' perceptions of geriatric practice in Medicare HMOs

Smith, M.A.; Shahar, E.; McGovern, P.G.; Kane, R.L.; Doliszny, K.M.; Arnett, D.K.; Luepker, R.V., 1999:
HMO membership and patient age and the use of specialty care for hospitalized patients with acute stroke: The Minnesota Stroke Survey

Feldman, R.; Given, R.S., 1998:
HMO mergers and Medicare: the antitrust issues

Christianson, J.B.; Feldman, R.D.; Wholey, D.R., 1998:
HMO mergers: estimating impact on premiums and costs

Elrod, J.L., 1994:
HMO mergers: we've only just begun

Keene, K.K.; McDonald, J.W., 1980:
HMO obstacles: program use will depend on motivation

Anonymous, 1980:
HMO option keeps costs down: survey

Lewis, B.E., 1994:
HMO outcomes research: lessons from the field

Morrissey, J., 2000 :
HMO outsources technology services

Bredesen, A.C., 1985:
HMO participation. Must you surrender control?

Ayers, J.; Benson, L.; Bonhag, R., 1996:
HMO partnering: the provider dilemma

Anonymous, 1997:
HMO patients receive less costly end-of-life care

Wagner, L., 1990:
HMO payment increase proposal meets resistance

Hadley, J.; Mitchell, J.M., 1999:
HMO penetration and physicians' earnings

Decker, S.L.; Hempstead, K., 1999:
HMO penetration and quality of care: the case of breast cancer

Baker, L.C.; Corts, K.S., 1996:
HMO penetration and the cost of health care: market discipline or market segmentation?

Polsky, D.; Kletke, P.R.; Wozniak, G.D.; Escarce, J.J., 2001:
HMO penetration and the geographic mobility of practicing physicians

Mukamel, D.B.; Zwanziger, J.; Tomaszewski, K.J., 2002:
HMO penetration, competition, and risk-adjusted hospital mortality

Clement, J.P.; Grazier, K.L., 2001:
HMO penetration: has it hurt public hospitals?

Barnett, A.E.; Mayer, T., 1993:
HMO performance assessment: group practice strategies and considerations

Luft, H., 1980:
HMO performance: current knowledge and questions for the 1980s. A research agenda considered

Sullivan, K., 2002:
HMO performance: the debate goes on

Rose, D.G., 1996:
HMO pharmacist in a contract hospital

Schectman, J.M.; Elinsky, E.G.; Kanwal, N.K.; Ott, J.E., 1995:
HMO physician attitudes toward drug cost containment strategies

Anonymous, 1989:
HMO physician incentive payments: modify ban?

Anonymous, 2002:
HMO physician incentives and trust: are patients bothered?

Podolsky, G., 1987:
HMO physician reimbursement. The case for fee-for-service IPAs

Hartman, N.S., 1996:
HMO physicians and the media

Bronow, R., 1992:
HMO physicians' shared risk pools are dangerous to patients' health

Bachman, K.H.; Freeborn, D.K., 1999:
HMO physicians' use of referrals

Weissenstein, E., 1999:
HMO picture unclear. New managed-care studies present contradictory data

Miller, R.H.; Luft, H.S., 2002:
HMO plan performance update: an analysis of the literature, 1997-2001

Anonymous, 1977:
HMO plans to expand to meet membership needs

Nash, D.B., 1985:
HMO practice: advantages and disadvantages

Anonymous, 1995:
HMO premiums take a new direction: downward ... but the trend isn't universal

Weissenstein, E., 1994:
HMO premiums to drop 1.2%

Forsyth, R.A., 1997:
HMO productivity: back to basics

Anonymous, 1979:
HMO profile: consumer group important in Crosslands Health Plan

Kenkel, P.J., 1989:
HMO profit outlook begins to brighten

Woolhandler, S.; Himmelstein, D.U.; Hellander, I.; Wolfe, S.M., 2001:
HMO profits and quality

Lake, T.; Gold, M.; Hurley, R., 2002:
HMO provider networks in Medicare+Choice: comparing Medicare and commercial lines of business

Born, P.; Geckler, C., 1997:
HMO quality and financial performance: is there a connection?

Neil, N., 1993:
HMO quality assessment partnerships improve health care

Kenkel, P.J., 1990:
HMO quality perceptions differ--survey

Cunningham, L., 1995:
HMO quality reports: time for marketers to get involved

Harris, N., 1993:
HMO rate increases slowed last year

Wise, D., 1994:
HMO ratings spur quality efforts

Lutz, S., 1994:
HMO receivables up 26%

Rosenberg, D.; Bonner, P.G.; Scotti, D.J.; Wiman, A.R., 1990:
HMO reenrollment determinants: a multivariate revisit

Anonymous, 1975:
HMO regulations don't resolve problems which Taft-Hartley funds will have with dual choice

Thomas, J.E., 1987:
HMO reimbursement and the radiologist

Kenkel, P.J., 1991:
HMO reimbursement to rise 6%

SoRelle, R., 1997:
HMO report

Moulton, G., 1999:
HMO research network to focus on cancer prevention and control

Anonymous, 1992:
HMO resources

Tokarski, C., 1991:
HMO review to switch to random samples

Traska, M.R., 1990:
HMO review: will it test whether employers care about quality?

Jensen, J., 1996:
HMO satisfaction slipping: consumers

Anonymous, 1985:
HMO saving questioned as review plan emerges

Hamilton, B.H., 1999:
HMO selection and Medicare costs: Bayesian MCMC estimation of a robust panel data tobit model with survival

Kenkel, P.J., 1994:
HMO settles out of court; investors appear relieved

Wenzel, F.J.; Wasserman, F.W.; Shulman, S.J., 1985:
HMO shakeout

Gardner, J., 2000:
HMO showdown. As House vote nears, managed-care lobby works to cut losses

Rahn, G., 1987:
HMO sponsorship: a growing strategy for hospitals

Anonymous, 1997:
HMO stirs debate with outpatient mastectomy push

Johnson, D.E., 1994:
HMO stock options good for hospitals?

Lutz, S.; Greene, J., 1995:
HMO stocks fall with news of Fla. Medicaid rate cut

Kenkel, P.J., 1989:
HMO stocks up

Birnbaum, R.W., 1988:
HMO strategic issues and options in a changing environment

Anonymous, 1995:
HMO strategies for improving childhood immunization rates

Gallagher, P.A., 1996:
HMO strategies for managing workers' compensation claims

Anonymous, 1980:
HMO study assesses cost, quality, access to care

Rauber, C., 1999:
HMO study finds $768 million loss

Anonymous, 1998:
HMO study identifies leading cancers among seniors, offers cost and utilization benchmarks

Anonymous, 1979:
HMO study refutes single national plan

Staver, S., 1980:
HMO subsidies come under fire

Parker, P.L., 1978:
HMO success: product of teamwork and competition

Kenkel, P.J., 1991:
HMO sues Wis. to raise surplus requirement

Carnall, D., 2000:
HMO sues charity over domain name

Kenkel, P.J., 1991:
HMO sues to recover Medicare funds

Baldwin, M.F., 1987:
HMO supporters praise HCFA's decision to terminate Medicare contract with IMC

Anonymous, 1979:
HMO surveys: most members select primary care physicians, give high ratings to medical services

Clement, D.G., 1995:
HMO survival: determination of optimal size

Magill, A.M., 1993:
HMO tactics hurt solo specialist's practice

Kertesz, L., 1994:
HMO targets new markets

Kenkel, P.J., 1992:
HMO to base hospital pay on quality

Mathias, J.M., 1997:
HMO to contract with teams for surgeries

Lutz, S., 1991:
HMO to finance trials of cancer treatment

Blitzer, C.G., 1981:
HMO to open its doors after a 6 1/2 year wait

Comper, A., 1978:
HMO up-date: is there a marketplace?

Fox, P.D., 1989:
HMO update. Where are they headed?

Rochester, J., 1981:
HMO update: the Detroit experience

Anonymous, 2002:
HMO use of capitation for physicians continues to grow

Chewnew, M., 1995:
HMO use of diagnostic tests: a review of the evidence

Anonymous, 1997:
HMO utilization found similar between enrollees with and without prior health insurance

Leventhal, R.C., 1991:
HMO versus private care medical systems: a study to determine the aging consumers' satisfaction with medical care under these two systems

Caputo, R.K.; Dolinsky, A.L., 1990:
HMO viability and the economically disadvantaged

BeSaw, L., 1996:
HMO vs case management

Franz, J., 1983:
HMO will engineer enrollment gains with clinic in renovated train building

Kosterlitz, J., 1987:
HMO "risk contracting" has its risks

Cotton, P., 1989:
HMO's 'hidden incentives' for doctors called fraud

Shouldice, R.G., 1988:
HMO's adverse selection affects physician groups

Cruz, P.C., 1991:
HMO's and physician practice groups: will you still love me tomorrow?

Tammelleo, A.D., 1997:
HMO's binding arbitration clause does not bar suit v. nurses. Case in point: Colorado Permanente Medical Group v. Evans 926 P. 2d 1218--CO (1996)

Anonymous, 2002:
HMO's call for binding reforms on managed care industry--"PARCA" targeted

Anonymous, 1999:
HMO's data-driven cardiac network brings new meaning to provider competition

Anonymous, 1997:
HMO's doctors teach each other to improve communication skills

McLaughlin, N., 1986:
HMO's dramatic rate of growth to shift to Frost Belt, rural areas

Morrissey, J., 1995:
HMO's lawsuit will test NCQA's growing clout

Fink, R., 1978:
HMO's proven to reduce costs

Kenkel, P.J., 1990:
HMO's selective pharmacy agreements trim spiraling costs but irk independents

Weiss, R., 1996:
HMO's senior enrollees hear a familiar voice

Maes, J., 1979:
HMO's will double, peak out in '80s: HEW predictions

O'Connell, J.O.; Neale, J.F., 1998:
HMO's, cost containment, and early offers: new malpractice threats and a proposed reform

Lazarus, S.S., 1987:
HMO, PPO & IPA systems survey

Kertesz, L., 1996:
HMO, PPO enrollment growth solid

Anonymous, 2002:
HMO, insurance policies threaten HIV care: interview with Dr. X. Interview by John S. James

Lewis, J.B.; Steiner, J.E., 1988 :
HMO, physicians cement relationship with contract that serves both sides

Parsons, D.W., 1996:
HMO-bashing: a most popular Washington pastime

Krasner, W., 1984:
HMO-employer contracts

Bowe, J., 1993:
HMO. A new home for long-term care

Louden, T.L.; Leavenworth, E.R., 1986:
HMO/PPO perspectives on home care: a national survey

Kovener, R.R., 1987:
HMO/hospital balance: relative strength is important in a managed care program

Coile, R.C., 1994:
HMO/insurer-provider partnerships: creating the "ultimate model" for hospitals, physicians and HMOs/insurers

Doherty, J.F., 1983:
HMO: an acronym here to stay

Anonymous, 1975:
HMO: it's working in Detroit

Wolinsky, F.D.; Marder, W.D., 1982:
HMO: the concept, new evidence, implications

Sansone, J.D., 1975:
HMO? PSRO? How do you know?

Hume, S.K., 1992 :
HMOS' continuum of care. How HMOs target their services to meet the needs of the elderly

Havighurst, C., 1996:
HMOphobia: who's afraid of managed care mergers?

Bazzoli, F., 1996:
HMOs & CPRs. HMOs clarifying electronic records strategies

Glick, S.K.; Taylor, M., 1986:
HMOs & home care: an overview

O'Brien, M., 1986:
HMOs & home care: cost containment allies

Cenac, D., 1987:
HMOs ... where are you?

Kertesz, L., 1995:
HMOs adapt to Medicaid market

Anonymous, 1999:
HMOs address patients' complaints

Anonymous, 1999:
HMOs adopt external review programs

Yanish, D., 1984:
HMOs advertising heavily to sign up government workers in Madison, WI

Anonymous, 1997:
HMOs aggressively developing disease management programs; cost reductions reported

Anonymous, 1998:
HMOs agree on standard site visit protocol

Johnsson, J., 1988:
HMOs alter strategy to gain enrollees in tough N.Y. market

Pope, T., 1994:
HMOs and CHCs join forces

Heilicser, B.J., 1995:
HMOs and EMS. Is it too late to SOS?

Steinman, T.I., 1998:
HMOs and ESRD: a gloomy scenario

Hannah, R.G., 1999:
HMOs and ESRD: can it work?

Felch, W.C., 1985:

Neuschler, E., 1987:
HMOs and Medicaid: how can the states sustain market interest?

Dunmire, S.N., 1987:
HMOs and PPOs in review

Beck, D.F.; Freeman, R.A., 1985:
HMOs and PPOs will come calling

Millikan, D.L., 1986:
HMOs and PPOs. How do they stack up?

Cotler, M.P., 1997:
HMOs and academic medicine: are they both deaf to patients?

Parkman, C.A., 2002:
HMOs and alternative care

Jordahl, G., 1992:
HMOs and employers unite to collect outcomes data

Seidman, B., 1979:
HMOs and health care for all Americans

Ellwood, P.M.; Malcolm, J., 1980:
HMOs and health delivery reform

Bernstein, A.B.; Bernstein, J., 1996:
HMOs and health services research: the penalty of taking the lead

McNiff, M.L., 1986:
HMOs and home care: a VNA's experience

Cossette, M., 1987:
HMOs and home care: defining the partnership

Krasner, W.L.; Goff, A.R., 1987:
HMOs and home health agencies: legal issues

Dombi, W.A., 1989:
HMOs and home health care: developing a relationship

Brown, R.E., 1987:
HMOs and home healthcare--a new challenge for DME suppliers

Alter, J.; Piturro, M., 1992:
HMOs and insurers

Sfikas, P.M., 1998:
HMOs and liability

Biblo, J.D., 1995:
HMOs and medical ethics

Bronzino, J.D., 1997:
HMOs and medical technology

Blostin, A.; Marclay, W., 1983:
HMOs and other health plans: coverage and employee premiums

Wallace, A.P., 1993:
HMOs and physicians without board certification

Johnson, D.E., 1995:
HMOs and providers will avoid real price wars

Becker, S., 2001:
HMOs and quality care for HIV -- interview with Stephen Becker, M.D. Part 1 of 2. Interview by John S. James

Becker, S., 2001:
HMOs and quality care for HIV -- interview with Stephen Becker, M.D. Part 2 of 2. Interview by James S. James

Firshein, J., 1997:
HMOs and self-insurance go head to head

Uva, J.L., 1996:
HMOs and the barriers to access for the pediatric population requiring emergency medical services

Stano, M., 1997:
HMOs and the efficiency of healthcare delivery

Coleman, J.R., 2002:
HMOs and the future of telemedicine and telehealth. Part 1

Coleman, J.R., 2002:
HMOs and the future of telemedicine and telehealth: Part 2

Luft, H.S., 1979:
HMOs and the medical care market

Bartlett, L., 1980:
HMOs and the poor: problems and possibilities

Riggs, R.T., 1996:
HMOs and the seriously mentally ill--a view from the trenches

Silverstein, G.; Fairman, K., 1989:
HMOs and the small business market

Bohm, D.A., 1999:
HMOs and vicarious liability. Implying control over physicians may expose HMOs

Iglehart, J.K., 1978:
HMOs are alive and well in the Twin Cities region

Briggs, B., 2001:
HMOs are drilling for HEDIS data

Doherty, J., 1993:
HMOs are poised to lead

Johnson, D.E., 2001:
HMOs are reduced to being prepaid indemnity health insurers

Benko, L.B., 2002:
HMOs aren't shedding tiers. First it was drug pricing; now health plans are turning to 'select' providers

Wallace, C., 1983:
HMOs await new Medicare option

Strazewski, L., 1988:
HMOs balk at efforts to promote their use of standardized data

Wallace, C., 1986:
HMOs battle for market share throughout Southern California

Kertesz, L., 1996:
HMOs battling horror stories, lawmakers

Lefton, D., 1982:
HMOs boom in Twin Cities

Kenkel, P.J., 1988:
HMOs boosting premiums

Kenkel, P.J., 1988:
HMOs can no longer hazard a guess on costs

Wallace, C., 1984:
HMOs can seek Medicare business, but will reimbursement be sufficient?

Moore, J.D., 1999:
HMOs cause systems' rating hits. And when plans are sold, the outlook may improve

Henderson, J.A., 1987:
HMOs challenge healthcare marketers

Kenkel, P.J., 1991:
HMOs choosing IPA partners with care

Baldwin, M.F., 1986:
HMOs claim victory in review fight

Rayner, G., 1989:
HMOs come to Britain

King, D.H., 1979:
HMOs come to Georgia--responsibility cost control without radical change

Anonymous, 1994:
HMOs continue to change the health care marketplace

Wallace, C., 1986:
HMOs converting to for-profit status could face more rigorous reviews

Alt, S.J., 1994:
HMOs demand better hospital deals as markets shift to managed care

Moore, J.D., 1999:
HMOs do credit to hospital owners

Lucas, J., 1994:
HMOs do not allow NP practice

Harrison, D.H.; Kimberly, J.R., 1982:
HMOs don't have to fail

Grandle, G.B., 1992:
HMOs drove me out of Minnesota

Perry, L., 1988:
HMOs emphasizing customer service efforts

Anonymous, 1999:
HMOs encourage group therapy

Morrissey, J., 1997:
HMOs enter Internet age. Plans begin electronic interaction with enrollees

Anonymous, 2000:
HMOs exiting Medicare will affect nearly 1 million

Anonymous, 1983:
HMOs expect a big influx of Medicare patients

Kenkel, P.J., 1989:
HMOs face more financial restrictions as regulators strive to protect enrollees

Henderson, J.A., 1988:
HMOs facing normal travails of a young industry; those that evolve will survive

Strazewski, L., 1988:
HMOs find inexpensive ways to provide utilization data

Bowe, J., 1984:
HMOs for the elderly

Kenkel, P.J., 1991:
HMOs form networks to serve firms with offices in more than one region

Anonymous, 1995:
HMOs found to use few standards in contracts for tertiary care

Anonymous, 1983:
HMOs get high marks in survey

Anonymous, 2002:
HMOs have stake in quelling anger at drug store counters

Goldwyn, R.M., 1991:
HMOs have turned hospital doors into stone walls

Hamer, R.L., 2002:
HMOs healthier, less abused, but fail to increase market share. Interview by Patrick Mullen

Kenkel, P.J., 1993:
HMOs hope to head off price controls

Boisvert, R.; Gosselin, R.; Pineault, R., 1987:
HMOs in Canada: what to expect

Anonymous, 1982:
HMOs in Twin Cities feel pressure to advertise

Nayar, S., 1999:
HMOs in harmony. N.H. plans write common set of preventive-care guidelines

Langwell, K.M.; Rossiter, L.F.; Hadley, J.P.; Nelson, S.L.; Nelson, L.M.; Berman, K.A., 1986:
HMOs in the Medicare market. Part 1

Langwell, K.M.; Rossiter, L.F.; Hadley, J.P.; Nelson, S.L.; Nelson, L.M.; Berman, K.A., 1986:
HMOs in the Medicare market. Part 2--Operational issues

Anonymous, 1982:
HMOs in the Twin Cities have fallen on hard times and are laying off doctors

Jadach, T., 1985:
HMOs in the evolving healthcare industry

Masso, A.R., 1984:
HMOs in transition: what the future holds

Kight, D., 1988:
HMOs increase staff and alter strategy for CHAMPUS account

Arvantes, J.C.; Bader, B.S.; Veatch, R., 1993:
HMOs invest in health promotion and learn to target their efforts

Weil, T.P., 1997:
HMOs irreversibly changing the role of the hospital

Kenkel, P.J., 1993:
HMOs join to blanket New England

de Lafuente, D., 1994:
HMOs join to vie for contracts that move Calif. Medicaid patients to managed care

Anonymous, 1981:
HMOs look for increased private investments

Iori, R., 1988:
HMOs look to rural market despite predominance of small employers

Anonymous, 1998:
HMOs losses: new provider warning signals for 1998

Johnson, D.E., 1999:
HMOs may be ready to drop costly physicians

Demkovich, L.E., 1982:
HMOs may face a lean future with declining government support

Strazewski, L., 1988:
HMOs may look to group purchasing to stem costs and manage materials

Anonymous, 2000:
HMOs may not screen diabetics adequately for complications related to their disease

Kertesz, L., 1995:
HMOs mine workers' comp market

Kertesz, L., 1995:
HMOs move east

Grimaldi, P.L., 1997:
HMOs must submit Medicare HEDIS

Matlock, M.A., 1980:
HMOs need employer support; study

Leider, H.L., 2001:
HMOs need to share gains of DM programs. Physician are more likely to buy in if they see better outcomes--and financial rewards that go with them

Anonymous, 1978:
HMOs not regulated in all states; NAIC develops uniform model law

Anonymous, 1977:
HMOs not widely accepted by Taft-Hartley funds

Anonymous, 1997:
HMOs now cover nearly 30% of insured Americans

Appleby, C., 1995:
HMOs on the move. Is your town big enough for the both of you?

Jensen, J., 1992:
HMOs outscore both PPOs, traditional indemnity plans in degree of customer satisfaction

Wagner, L., 1992:
HMOs plan 9.6% premium hikes

Kertesz, L., 1996:
HMOs plan campaign to fight bad image

Greene, J., 1987:
HMOs posted large gains in enrollment, but most saw profits decline during 1986

Punch, L.; Johnson, D.E., 1983:
HMOs predict rapid enrollee growth as consumers' cost concerns mount

Landis, N.T., 2000:
HMOs pressed by rising drug costs, industry report shows

Whitmore, H., 1995:
HMOs provide comprehensive care to mothers and newborns

Jensen, J., 1995:
HMOs put satisfaction data to work

Pierce, C., 1995:
HMOs rallying physicians to use electronic records

Anonymous, 1995:
HMOs reach out to Medicare beneficiaries

Kertesz, L., 1995:
HMOs reduce service use--study

Anonymous, 1994:
HMOs remain a riskier proposition than PPOs

Vastag, B., 2001:
HMOs report quality improvements

Morrissey, J., 1999:
HMOs rule in Boston market. But costs, utilization are high

Kuntz, E.F., 1983:
HMOs run path of consolidation

DiBlase, D., 1985:
HMOs say competition keeps 1986 rate increases moderate

Kenkel, P.J., 1988:
HMOs say gatekeeper system cuts costs, boosts quality

Jaklevic, M.C., 1996:
HMOs scale back ownership of doc groups

Buss, M.L., 1986:
HMOs second decade: 1983-1993. Proposed response to new challenges

Wagner, M., 1993:
HMOs see drug price hikes double in wake of Medicaid 'best price' legislation--GAO

Anonymous, 1988:
HMOs seek AAAHC (Accreditation Association for Ambulatory Health Care) accreditation to bolster marketing, recruiting

Kenkel, P.J., 1994:
HMOs seek more safeguards as medical groups integrate

Jaklevic, M.C., 1995:
HMOs seek stricter PHO oversight

Tatge, M., 1985:
HMOs seeking benefit packages for psychiatric, substance abuse

Moore, J.D., 1995:
HMOs selected for St. Louis Medicaid program

Casey, M.; Klingner, J., 2000:
HMOs serving rural areas: experiences with HMO accreditation and HEDIS reporting

Lefton, D., 1982:
HMOs set sights on Medicare market

Henderson, J.A., 1988:
HMOs set to reverse financial fortunes

Johnson, D.E., 1988:
HMOs should join in follow-up study to show commitment to quality

Sirois, P., 2002:
HMOs should prepare now to get handle on injectables

Johnson, D.E., 1988:
HMOs should stress quality tests in light of pap smear controversy

Kenkel, P.J., 1991 :
HMOs show new signs of consolidation

Gilbert, J.A., 1998:
HMOs slow to embrace client/server systems

Kahn, W.J., 2000:
HMOs still avoid meaningful patient care reform

Anonymous, 2002:
HMOs still favor capitation, long-term trends show

Kenkel, P.J., 1994:
HMOs strive to prove savings, battle HCFA payment system

DiBlase, D., 1985:
HMOs support end to protective legislation

Morrissey, J., 1996:
HMOs taking time on link

Goedert, J., 1997:
HMOs test the Internet

Carlova, J., 1985:
HMOs that treat more than illness

Benko, L.B., 2002:
HMOs thriving but still cautious

Scott, L., 1997:
HMOs tighten own reins. In Minn., plans lead passage of patient protection law

Albertson, D., 1985:
HMOs to compete for Medicare patients

Feldman, A., 1988:
HMOs try formularies in effort to curb prescription costs

Anonymous, 1999:
HMOs try new tactics to stand out in the marketplace

Morain, C., 1992:
HMOs try to measure (and reward) "doctor quality"

Kakaviatos, P., 1993:
HMOs under Clinton reforms may face bumpy road to growth

Fineman, H., 1998:
HMOs under the knife. The capital races to crack down on managed care

Anonymous, 1988:
HMOs weigh Medicare gamble

Brink, S., 1998:
HMOs were the right Rx. Americans got lower medical costs--but also more worries

Simler, S.L., 1981:
HMOs will be high risk investments through '80s; need 7% profit margins

Brown, B.J., 2000:
HMOs will be rewarded for taking sick patients

Johnson, D.E., 1994:
HMOs will enroll more people, slash utilization

Friedman, E., 1988:
HMOs will hang on to incentive

DeWitt, A.L., 1998:
HMOs won't look twice at AMA's model agreement

Anonymous, 1998:
HMOs' 1997 losses may continue to affect providers in 1999

Franz, J., 1984:
HMOs' aggressive marketing spurs leap in enrollment...and GAO probe

Anonymous, 1990:
HMOs' and PPOs' role in health benefits

Dalzell, M.D., 1997:
HMOs' delicate balancing act: the art of setting copayments

Anonymous, 1980:
HMOs' federal mandate may face legal challenge

Studin, I., 1996:
HMOs' question: to pay and deliver or just pay?

Kenkel, P.J., 1992:
HMOs' savings have 'spillover effect'--studies

Johnson, D.E., 1996:
HMOs' stock debacle changes the game

Wiener, B.M., 1986:
HMOs, PPOs bringing more risk sharing to physicians

Zaremski, M.J., 2002:
HMOs, accountability, and the death of ERISA preemption

Weissburg, C.; Waxman, J.M., 1982:
HMOs, doctor groups and antitrust laws: an overview

Anonymous, 1999:
HMOs, employers happier with their PBMs

James, J.S., 2002:
HMOs, health insurance: more problems

Kenkel, P.J., 1990:
HMOs, hospitals link up for the long term

Luft, H.S., 1995:
HMOs, market competition, and premium cost

Butler, R.J.; Hartwig, R.P.; Gardner, H., 1997:
HMOs, moral hazard and cost shifting in workers' compensation

Baldwin, M.F., 1985:
HMOs, other prepaid plans rushing to get federal Medicare qualification

Dalzell, M.D., 2000:
HMOs, physicians discover they really need each other

Lutz, S., 1995:
HMOs, providers at odds over Texas bill

Kertesz, L., 1996:
HMOs, providers sharing data key to making capitation work

Jaklevic, M.C., 1996:
HMOs, providers using team sell

Anonymous, 2002:
HMOs--HMO Act--coverage of basic health serices--home health care. Juliano v. HMO of New Jersey

Iglehart, J.K., 1978:
HMOs--an idea whose time has come?

House, S.G., 1981:
HMOs--medicine for feverish healthcare costs

Serafini, M.W., 1998:
HMOs--the good guys again?

Anonymous, 1997:
HMOs. From red to pink

Petty, R., 1986:
HMOs. It ain't what you do but the way that you do it

Clyde, R.D., 1986:
HMOs. Texas outlook "promising."

Bronzino, J.D., 1998:
HMOs: a biomedical engineering perspective

McMorran, W.C., 1989:
HMOs: a form of LTC insurance

Platt, D., 1996:
HMOs: a solution

Anonymous, 1994:
HMOs: an industry snapshot

Warner, J.P., 1987:
HMOs: another step forward in law and business

Anonymous, 1980:
HMOs: another surge in growth ahead

Falkson, J.L., 1979:
HMOs: coming of age in the '80s

Michenzi, A.R.; Miller, P.M., 1986:
HMOs: competition, pricing, and profits

Federa, R.D., 1983:
HMOs: competitive threat or strategic opportunity?

Snyder, J.D.; Bale, C., 1983:
HMOs: competitor or investment opportunity?

Rhein, R.W., 1978:
HMOs: feds vow to make them grow

Schwartz, T., 1988:
HMOs: fight for and against intensifies

Luft, H.S., 1985:
HMOs: friends or foes?

Kaufmann, S.J.; Verwey, V.A., 1984:
HMOs: injection of competition

Millikan, D.L.; Origer, D.L., 1987:
HMOs: looking behind the facade to establish true value

Halpern, S., 1986:
HMOs: maintenance or management?

Anonymous, 2018:
A Medical Witness on Medical Ethics and Things in General

Schuh, D., 1994:
HMOs: more to come

Cohelan, J., 1979:
HMOs: one effective solution to rising health costs

Mayer, T.R.; Mayer, G.G., 1986:
HMOs: origins and development

Ashford, L.J., 1980:
HMOs: past, present, future

Peck, P., 1987:
HMOs: physicians' experiences explored

Winner, R.G., 1978:
HMOs: putting the clamps on soaring medical costs

Snedeker, T.E.; Kuhns, M.L., 1981:
HMOs: regulations, problems and outlook

O'Malley, S., 1997:
HMOs: responding to bad report cards

Rayner, G., 1985:
HMOs: set for a British invasion?

Schwartz, H., 1987:
HMOs: the bloom is off the rose

Anonymous, 1981:
HMOs: the financial picture

McGowan, D.T., 1998:
HMOs: the good and the bad

Pattison, E.H., 1979:
HMOs: the real hang up

Doherty, J.F., 1979:
HMOs: the road to good health care

Cooney, E.K., 1986:
HMOs: where are the savings?

Lyons, L.J., 1978:
HMOs: where are they going? Part I

Carlier; Lo; Lo; Wan; Williams, 2000:
HMPA promotes retro-aldol reaction, resulting in syn-selective addition of lithiated 1-naphthylacetonitrile to aromatic aldehydes

Hornig, M.; Mozley, P.D.; Amsterdam, J.D., 1998:
HMPAO SPECT brain imaging in treatment-resistant depression

Moriarty, J.; Eapen, V.; Costa, D.C.; Gacinovic, S.; Trimble, M.; Ell, P.J.; Robertson, M.M., 1997:
HMPAO SPET does not distinguish obsessive-compulsive and tic syndromes in families multiply affected with Gilles de la Tourette's syndrome

Grünwald, F.; Horn, R.; Rieker, O.; Klemm, E.; Menzel, C.; Möller, H.J.; Biersack, H.J., 1993 :
HMPAO-SPECT in Alzheimer-type dementia and major depression with memory disorders

Anonymous, 1985:
HMQ survey: a mandate for high-quality health care

Thomas, G.P.; Gerlach, U.; Antzelevitch, C., 2002:
HMR 1556, a potent and selective blocker of slowly activating delayed rectifier potassium current

Ma, Z.; Florjancic, A.S., 2002:
HMR-3562. Aventis Pharma

McNeill Love, R.M.; Stapley, S.A., 1999:
HMS Illustrious, OCEAN WAVE 97 and the medical branch

Burger, R.; Schorn, C.; Bigler, P., 2001:
HMSC: simultaneously detected heteronuclear shift correlation through multiple and single bonds

Williams, M.M.; Tyfield, L.A.; Jardine, P.; Lunt, P.W.; Stevens, D.L.; Turnpenny, P.D., 1999:
HMSN and HNPP. Laboratory service provision in the south west of England--two years' experience

Baethmann, M.; Göhlich-Ratmann, G.; Schröder, J.M.; Kalaydjieva, L.; Voit, T., 1998:
HMSNL in a 13-year-old Bulgarian girl

Permi; Sorsa; Kilpelainen; Annila, 1999:
HN(alpha/beta-COCA-J) experiment for measurement of (1)J(C'C(alpha)) couplings from two-dimensional

Roald, H.E.; Barstad, R.M.; Engen, A.; Kierulf, P.; Skjørten, F.; Sakariassen, K.S., 1994:
HN-11500--a novel thromboxane A2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions

Sasaki, H., 1995:
HN7-3/fork head (winged-helix) transcription factor family in dorso-ventral pattern formation of vertebrate embryos

Löhr, F.; Pfeiffer, S.; Lin, Y.J.; Hartleib, J.; Klimmek, O.; Rüterjans, H., 2001:
HNCAN pulse sequences for sequential backbone resonance assignment across proline residues in perdeuterated proteins

Weisemann, R.; Löhr, F.; Rüterjans, H., 1994:
HNCCH-TOCSY, a triple resonance experiment for the correlation of backbone 13C alpha and 15N resonances with aliphatic side-chain proton resonances and for measuring vicinal 13CO,1H beta coupling constants in proteins

Williams, C., 1995:
HNE Diagnostics Dopplex ultrasound machines

Arrese, M.; Karpen, S.J., 2002:
HNF-1 alpha: have bile acid transport genes found their "master"?

Sasaki, H.; Hogan, B.L., 1994:
HNF-3 beta as a regulator of floor plate development

Ang, S.L.; Rossant, J., 1994:
HNF-3 beta is essential for node and notochord formation in mouse development

Antes, T.J.; Levy-Wilson, B., 2001:
HNF-3 beta, C/EBP beta, and HNF-4 act in synergy to enhance transcription of the human apolipoprotein B gene in intestinal cells

Olsen, J.; Laustsen, L.; Troelsen, J., 1994:
HNF1 alpha activates the aminopeptidase N promoter in intestinal (Caco-2) cells

Hansen, A.J.; Lee, Y.H.; Gonzalez, F.J.; Mackenzie, P.I., 1997:
HNF1 alpha activates the rat UDP glucuronosyltransferase UGT2B1 gene promoter

Wenink, A.C.; Symersky, P.; Ikeda, T.; DeRuiter, M.C.; Poelmann, R.E.; Gittenberger-de Groot, A.C., 1999:
HNK-1 expression patterns in the embryonic rat heart distinguish between sinuatrial tissues and atrial myocardium

Puisieux, A., 1999:
HNPCC syndrome, microsatellite instability and NF1 gene alteration

Seki, T.; Curiel, D.T.; Naruse, M.; Takano, K., 2000:
HO (heme oxygenase)/CO (carbon monoxide) system

D.Grey, A.D.N.J., 2002:
HO2*: the forgotten radical

Larimer, F., 2001:
HOBACGEN: homologous bacterial genes database

Dixon, N., 1982:
HOC promotes publicly accountable licensing system

Nolen, R.Scott., 2002:
HOD selects Walther to be president-elect

Chellappan, S.P., 2001:
HOG on the promoter: regulation of the osmotic stress response

Smart, O.S.; Neduvelil, J.G.; Wang, X.; Wallace, B.A.; Sansom, M.S., 1996:
HOLE: a program for the analysis of the pore dimensions of ion channel structural models

Silverman, B.G.; Sokolsky, O.; Tannen, V.; Wong, A.; Lang, L.; Khoury, A.; Campbell, K.; Qiang, C.; Sahuguet, A., 1999:
HOLON/CADSE: integrating open software standards and formal methods to generate guideline-based decision support agents

Silverman, B.G.; Moidu, K.; Clemente, B.E.; Reis, L.; Ravichandar, D.; Safran, C., 1997:
HOLON: a Web-based framework for fostering guideline applications

Silverman, B.G.; Jones, P.; Safran, C.; Reis, L.; Ravichandar, D.; Andonyadis, C.; Goldberg, H.; Marsh, J., 1999:
HOLON: extending Web document libraries via objects in order to support the health information infrastructure. Health Object Library Online

Rossouw, C.J.; Venkatesan, K., 2002:
HOLZ line analysis of lattice parameters in magnesium alloys

Botuck, H.M., 1993:
HOM: concerns and limitations

Weinstein, P.; Milgrom, P.; Domoto, P.K., 1993:
HOM: more limitations

Aguilera, E.; Recasens, M.; Flores, L.; Ricart, M.J.; Casamitjana, R.; Fernández-Cruz, L.; Esmatjes, E., 2002:
HOMA test in diabetic patients with simultaneous pancreas and kidney transplantation

Bonora, E.; Formentini, G.; Calcaterra, F.; Lombardi, S.; Marini, F.; Zenari, L.; Saggiani, F.; Poli, M.; Perbellini, S.; Raffaelli, A.; Cacciatori, V.; Santi, L.; Targher, G.; Bonadonna, R.; Muggeo, M., 2002:
HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study

Tesh, E.M.; Holditch-Davis, D., 1997:
HOME inventory and NCATS: relation to mother and child behaviors during naturalistic observations. Home Observation for Measurement of the Environment. Nursing Child Assessment Teaching Scale

Kupietzky, A., 1993:
HOME: learning process?

Yoffe, 1995:
HOMEOPATHY counterpoint clings to old view

Anonymous, 2000:
HON code of conduct for medical and health Web sites

Mra, Z.; Sussman, J.E.; Fenwick, J., 1998:
HONC measures in 4- to 6-year-old children. Horii Oral Nasal Coupling Index

Boyer, C.; Baujard, V.; Griesser, V.; Scherrer, J.R., 2001:
HONselect: a multilingual and intelligent search tool integrating heterogeneous web resources

Boyer, C.; Baujard, V.; Scherrer, J.R., 2001:
HONselect: multilingual assistant search engine operated by a concept-based interface system to decentralized heterogeneous sources

Lehman, A.; Black, R.; Ecker, J.R., 1996:
HOOKLESS1, an ethylene response gene, is required for differential cell elongation in the Arabidopsis hypocotyl

Kutzen, H.; Bennett, M., 2001:
HOP wins 3-year grant to develop palliative care program

Hutcheon, S.D.; Gillespie, N.D.; McMurdo, M.E.; Struthers, A.D., 2000:
HOPE and elderly patients attending geriatric day hospital. Heart Outcomes Prevention Evaluation Study

Chaturvedi, N., 2000:
HOPE and extension of the indications for ACE inhibitors? Heart Outcomes Prevention Evaluation

Marshall, S.M., 2000:
HOPE for all people with diabetes? Heart Outcomes Prevention Evaluation

Cohn, J.N., 2000:
HOPE for an ACE inhibitor

Kleinert, S., 1999:
HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Heart Outcomes Prevention Evaluation

Donnelly, R., 2001:
HOPE for diabetes in the new millennium. Heart Outcomes Prevention Evaluation

Jones, S.C.; Bowes, P.D.; Hall, E.; Connolly, V.; Kelly, W.F.; Bilous, R.W., 2001:
HOPE for patients with Type 2 diabetes: an application of the findings of the MICRO-HOPE substudy in a British hospital diabetes clinic

Schiffrin, E.L., 2000:
HOPE gives reason for hope. Heart Outcomes Prevention Evaluation

Sander, G.E.; Giles, T.D., 2002:
HOPE in PROGRESS--a tale of two trials: blood pressure reduction or drug mechanism?

Skolnick, A.A., 1996:
HOPE springs eternal for medical and health volunteers in 29 countries on 5 continents

Wiedorn, K.Hermann.; Olert, Jürgen.; Stacy, R.A.P.; Goldmann, T.; Kühl, H.; Matthus, J.; Vollmer, E.; Bosse, A., 2003:
HOPE--a new fixing technique enables preservation and extraction of high molecular weight DNA and RNA of > 20 kb from paraffin-embedded tissues. Hepes-Glutamic acid buffer mediated Organic solvent Protection Effect

Ferrell, B.R.; Virani, R.; Grant, M., 1998:
HOPE. Home Care Outreach for Palliative Care Education

Edlin, M., 1996:
HOPENET puts center on path for year 2000. City of Hope Medical Center

Anonymous, 2001:
HOPWA funding

Anonymous, 1995:
HOPWA funding preserved: Clinton unveils health plan

Anonymous, 1995:
HOPWA rescission approved; work begins on 1996 funding

Anonymous, 1995:
HOPWA's death in the House sets stage for negotiations with Senate

Xiong, L.; Ishitani, M.; Lee, H.; Zhu, J.K., 1999:
HOS5-a negative regulator of osmotic stress-induced gene expression in Arabidopsis thaliana

Canning, D.A., 2002:
HOSE: an objective scoring system for evaluating the result of hypospadias surgery

Strivens, M.A.; Middlehurst, P.; Brown, S.D.; Denny, P., 1997:
HOSEpipe--a WWW-hosted data management and analysis system for STS content mapping projects

Anonymous, 1998:
HOST conference finds health care ready for Internet. Healthcare Open Systems & Trials

Laden, G., 1998:
HOT MI pilot study. Hyperbaric Oxygen and Thrombolysis in Myocardial Infarction

Herpin, D.; Mallion, J.M.; Dahan, R.; Benkritly, A.; Boutelant, S.; Baguet, J.P.; Noir-Clerc, M., 1997:
HOT study: quality of the blood pressure control after 2 years follow-up. Pour le Groupe français de l'étude HOT

McDonald, M.D.; Blum, H.L., 1992:
HOT: the emergence of health oriented telecommunication applications

Towns, J., 2002:
HOTT resources. Health Opportunities for Today and Tomorrow

Spokes, K.; Bond, K.; Lowe, T.; Jones, J.; Illingworth, P.; Brimblecombe, N.; Wellman, N., 2002:
HOVIS -- The Hertfordshire/Oxfordshire Violent Incident Study

Hirakawa, M., 2001:
HOWDY: an integrated database system for human genome research

Spirov, A.V.; Borovsky, M.; Spirova, O.A., 2001:
HOX Pro DB: the functional genomics of hox ensembles

Spirov, A.V.; Bowler, T.; Reinitz, J., 1999:
HOX Pro: a specialized database for clusters and networks of homeobox genes

Sharpe, P., 1996:
HOX gene mutations--the wait is over

Zaraĭskiĭ, A.G., 2001:
HOX genes in embryo- and phylogenesis

Puliti, A.; Cinti, R.; Betsos, N.; Romeo, G.; Ceccherini, I., 1999:
HOX11L1, a gene involved in peripheral nervous system development, maps to human chromosome 2p13.1-->p12 and mouse chromosome 6C3-D1

Quaranta, M.T.; Petrini, M.; Tritarelli, E.; Samoggia, P.; Carè, A.; Bottero, L.; Testa, U.; Peschle, C., 1996:
HOXB cluster genes in activated natural killer lymphocytes: expression from 3'-->5' cluster side and proliferative function

Bijl, J.J.; van Oostveen, J.W.; Walboomers, J.M.; Horstman, A.; van den Brule, A.J.; Willemze, R.; Meijer, C.J., 1997:
HOXC4, HOXC5, and HOXC6 expression in non-Hodgkin's lymphoma: preferential expression of the HOXC5 gene in primary cutaneous anaplastic T-cell and oro-gastrointestinal tract mucosa-associated B-cell lymphomas

Smith, C.P.; Huger, F.P.; Petko, W.; Kongsamut, S., 1994:
HP 749 enhances calcium-independent release of [3H]norepinephrine from rat cortical slices and synaptosomes

Lutz, J.F., 2000:
HP Anesthesiology Village. A commercial subject server

Denis, P.; D.K.ster, E.; Nyst, J.F.; Deltenre, M., 1995:
HP serology as a screening method prior to upper gastro-intestinal endoscopy in young dyspeptic patients: a different point of view

Xu, L.; Wan, D.; Liu, Y., 1996:
HP8: the partial cDNA clone of a novel member of C/EBP gene family

Altamura, A.C.; Boin, F.; Maes, M., 2000:
HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment

Majewska, M.Dorota., 2001:
HPA axis and stimulant dependence: an enigmatic relationship

Kosten, T.A.; Ambrosio, E., 2001:
HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats

Cavanagh, G.; Dunn, A.N.; Chapman, C.E.; Metcalfe, P., 1997:
HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations

Corral, J.; González-Conejero, R.; Rivera, J.; Iniesta, J.A.; Lozano, M.L.; Vicente, V., 1997:
HPA-1 genotype in arterial thrombosis--role of HPA-1b polymorphism in platelet function

Watkins, N.A.; Schaffner-Reckinger, E.; Allen, D.L.; Howkins, G.J.; Brons, N.H.C.; Smith, G.A.; Metcalfe, P.; Murphy, M.F.; Kieffer, N.; Ouwehand, W.H., 2002:
HPA-1a phenotype-genotype discrepancy reveals a naturally occurring Arg93Gln substitution in the platelet beta 3 integrin that disrupts the HPA-1a epitope

Wiener, E.; Mawas, F.; Coates, P.; Hossain, A.K.; Perry, M.; Snachall, S.; Deb, P.; Rodeck, C.H.; Keler, T., 2001:
HPA-1a-mediated platelet interaction with monocytes in vitro: involvement of Fcgamma receptor (FcgammaR) classes and inhibition by humanised monoclonal anti-FcgammaRI H22

Price, J.; Lenney, W.; Duncan, C.; Green, L.; Flood, Y.; Daley-Yates, P.; Barnacle, H.; Efthimiou, J., 2002:
HPA-axis effects of nebulised fluticasone propionate compared with oral prednisolone in childhood asthma

Anonymous, 1988:
HPAC 88/89 info-dex. Annual desk reference to mechanical systems

Sponsler, J.L., 2002:
HPARSER: extracting formal patient data from free text history and physical reports using natural language processing software

Baas, D.; Barnstable, C.J., 1998:
HPC-7: a novel oligodendrocyte lineage protein which appears prior to galactocerebroside

Krull, I.S.; Liu, X.; Dai, J.; Gendreau, C.; Li, G., 1998:
HPCE methods for the identification and quantitation of antibodies, their conjugates and complexes

Zhang, B.L.; Yang, R.H.; Jin, S., 1996:
HPCE separation of protected amino acids and peptides

Bateman, C., 2001:
HPCSA AIDS cases under scrutiny

Bateman, C., 2002:
HPCSA probe chief resigns and speaks out

Benvenuti, S.; Masi, L.; Falchetti, A.; Mancini, L.; Formigli, L.; Zecchi, S.; Amorosi, A.; Tonelli, F.; Brandi, M.L., 1997:
HPE cells: a clonal endothelial cell line established from human parathyroid tissue (human parathyroid cell line)

Hermann, M.G., 1989:
HPEN therapy: assuring quality in home parenteral and enteral feeding

Abbas, M.I., 2001:
HPGe detector photopeak efficiency calculation including self-absorption and coincidence corrections for Marinelli beaker sources using compact analytical expressions

Lutz, S., 1991:
HPI cancels 20 small-hospital contracts

Schubert, S.; Sorsa, J.L.; Cuenca, S.; Fischer, D.; Jacobi, C.A.; Heesemann, J., 2000:
HPI of high-virulent Yersinia is found in E. coli strains causing urinary tract infection. Structural, functional aspects, and distribution

Kusubata, M.; Furuhashi, K., 1994:
HPLC (including FPLC and SMART)

Nnane, I.P.; Damani, L.A., 2001:
HPLC analysis of 4-chlorophenyl methyl sulphide and diphenyl sulphide and their corresponding sulphoxides and sulphones in rat liver microsomes

Aboul-Enein, H.Y.; Abu-Zaid, S., 2001:
HPLC analysis of S-adenosyl-L-methionine in pharmaceutical formulations

Matteson, K.J., 1995:
HPLC analysis of amino acids in inborn errors of metabolism